Target Healthcare REIT (LON:THRL) Sets New 52-Week High – Should You Buy?

Target Healthcare REIT (LON:THRL) hit a new 52-week high during mid-day trading on Monday . The stock traded as high as GBX 95 ($1.23) and last traded at GBX 91.80 ($1.19), with a volume of 3152406 shares trading hands. The stock had previously closed at GBX 92.80 ($1.20).

Target Healthcare REIT Stock Performance

The company has a current ratio of 7.20, a quick ratio of 1.52 and a debt-to-equity ratio of 34.92. The company’s 50-day simple moving average is GBX 84.53 and its 200-day simple moving average is GBX 85.90. The stock has a market capitalization of £575.37 million, a price-to-earnings ratio of 7.88, a PEG ratio of 1.48 and a beta of 0.44.

Target Healthcare REIT (LON:THRL) last posted its quarterly earnings data on Friday, March 14th. The company reported GBX 3.06 ($0.04) earnings per share for the quarter. Target Healthcare REIT had a net margin of 104.99% and a return on equity of 10.78%. On average, analysts expect that Target Healthcare REIT will post 6.2219101 EPS for the current year.

Target Healthcare REIT Company Profile

Our investment objective is to provide shareholders with an attractive level of income together with the potential for capital and income growth, from a portfolio of UK care homes, diversified by tenant, geography, and resident payment profile. We only invest in modern, purpose-built homes.